NCT03009721UnknownNot Applicable
A Non-interventional, Multi-center, Retrospective Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia (ROSE Study)
Daewoong Pharmaceutical Co. LTD.1 site in 1 country9,707 target enrollmentStarted: August 2016Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 9,707
- Locations
- 1
- Primary Endpoint
- Percent change from baseline in blood pressure (SBP/DBP)
Study Overview
Brief Summary
The purpose of this study is to investigate the effectiveness and safety of Olostar Tab in patients with essential hypertension and dyslipidemia
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 19 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Male or female ≥ 19
- •Patients have record of blood pressure (SBP/DBP) and LDL-C after prescription of Olostar Tab.
Exclusion Criteria
- •Patients that have participated clinical trials or PMS with Olostar Tab.
Outcomes
Primary Outcomes
Percent change from baseline in blood pressure (SBP/DBP)
Time Frame: At 8 Weeks
Percent change from baseline in LDL-Cholesterol (LDL-C)
Time Frame: At 8 Weeks
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Active, not recruiting
Not Applicable
Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar TabHyperlipidemiasHypertensionNCT05411887Daewoong Pharmaceutical Co. LTD.2,845
Completed
Phase 2
Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699Cushing's SyndromeNCT03606408RECORDATI GROUP127
Completed
Phase 3
Olmesartan Medoxomil Versus Losartan in Patients With HypertensionEssential HypertensionNCT00857285Daiichi Sankyo130
Completed
Phase 4
A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based TherapyRelapsed and/or Refractory Multiple MyelomaNCT03416374Takeda45
Completed
Not Applicable
Investigation of Preservative-Free Ophthalmic Solution in Ocular DrynessDry Eye SyndromesNCT05778942SIFI SpA35